Teva sells Overland Park business segment - Kansas City Business Journal
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceutical Industries Ltd. | Global Philadelphia Association
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharma News, Teva Pharma Quote, TEVA Quote - StreetInsider.com
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharma Gets Approval to Market Generic Nasal Spray for Opioid Overdoses - WSJ
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
teva News and latest stories | The Jerusalem Post
Teva | Partnership | Direct Relief
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Outsourcing active medicine ingredients leaves EU patients at risk
TEVA News Today | Why did Teva Pharmaceutical Industries stock go up today?
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva, one of the biggest generic makers, joins the the brand-name club
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva looks to amp up research collaborations, CEO says
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
